Saturday 7 November 2026
Export PGNY’s income statement to Excel — free account
Progyny, Inc.
PGNY Healthcare Healthcare Plans
Progyny, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.3 billion, up 10.4% from fiscal 2024.
- Revenue
- +8.91%
- EPS
- +115.3%
- Free cash flow
- +2.72%
Quarter to September 2026, against a year earlier
34.84
0.47
+1.37%
Follow PGNY
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
8 | 8 | 8 | 8 |
| 12.48% | 14.93% | 16.24% | 18.69% | ||
| 8.67% | 9.48% | 10.65% | 12.38% | ||
ROIC |
25.88% | 28.15% | 32.40% | 35.99% | |
Return on Tangible Assets |
15.43% | 22.45% | 24.97% | 33.15% | |
Average Days of Receivables |
62.39 | 74.41 | 71.70 | 67.94 | |
Free Cash Flow per Share |
2.24 | 2.28 | 2.28 | 2.36 | |
Free Cash Flow |
191.78 | 184.42 | 178.38 | 179.64 | |
Capital Expenditures |
(18.41) | (21.91) | (22.86) | (27.54) | |
| Other line items | |||||
Cash ROIC |
23.21% | 27.75% | 25.85% | 29.47% | |
Accounts Receivable Turnover |
5.66 | 4.59 | 4.95 | 5.34 | |
Accounts Payable Turnover |
8.98 | 6.47 | 6.76 | 7.42 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
46.01 | 58.70 | 56.13 | 53.72 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.39) | (0.36) | (0.34) | (0.31) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
17.01% | 16.65% | 16.02% | 15.48% | |
Share Based Compensation of Revenue |
10.23% | 9.21% | 8.18% | 7.18% | |
Operating CF/Net income |
3.59 | 3.05 | 2.56 | 2.28 | |
Depreciation/Fixed assets |
0.17 | 0.15 | 0.14 | 0.14 | |
Capex/Depreciation |
(3.72) | (4.12) | (3.98) | (3.90) | |
Revenue per Share |
15.05 | 15.98 | 16.77 | 17.56 | |
Operating CF per Share |
2.45 | 2.55 | 2.57 | 2.72 | |
Capex per Share |
(0.21) | (0.27) | (0.29) | (0.36) | |
Capex to Sales |
0.01 | 0.02 | 0.02 | 0.02 |
Columns are period end dates · fundamentals updated 6 Nov 2026